Together, these results in Figures 5–7 support a role for mTOR in lipid synthesis and utilization particularly in the HER2/PIK3CA-hyperactive breast cancer cells, which contribute to the antitumor efficacy of mTOR-targeted therapy. The gene discussed is ERBB2; the disease is breast carcinoma.